Korean Nationwide Surveillance of Antimicrobial Resistance in 2000 with special reference to vancomycin resistance in enterococci, and expanded-spectrum cephalosporin and imipenem resistance in gram-negative bacilli
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, K. | - |
dc.contributor.author | Kim, M. | - |
dc.contributor.author | Kang, S.H. | - |
dc.contributor.author | Kang, J.O. | - |
dc.contributor.author | Kim, E.-C. | - |
dc.contributor.author | Choi, T.Y. | - |
dc.contributor.author | Chong, Y. | - |
dc.contributor.author | Cho, H.C. | - |
dc.contributor.author | Ryoo, N. | - |
dc.contributor.author | Jeong, S.H. | - |
dc.contributor.author | Ha, G.Y. | - |
dc.contributor.author | Park, G.H. | - |
dc.contributor.author | Lee, N.Y. | - |
dc.contributor.author | Kim, W.-S. | - |
dc.contributor.author | Lee, W.G. | - |
dc.contributor.author | Kim, M. | - |
dc.contributor.author | Song, K.S. | - |
dc.contributor.author | Cho, J. | - |
dc.contributor.author | Hong, S.-I. | - |
dc.contributor.author | Uh, Y. | - |
dc.contributor.author | Hong, K.S. | - |
dc.contributor.author | Paik, I.K. | - |
dc.contributor.author | Pai, S.H. | - |
dc.contributor.author | Lee, H.S. | - |
dc.contributor.author | Jang, S.-J. | - |
dc.contributor.author | Park, A.J. | - |
dc.contributor.author | Rhim, C.H. | - |
dc.contributor.author | Lee, M.H. | - |
dc.contributor.author | Song, W. | - |
dc.contributor.author | Park, Y.J. | - |
dc.contributor.author | Shin, J.H. | - |
dc.contributor.author | Hong, S.G. | - |
dc.contributor.author | Sun, Y.K. | - |
dc.contributor.author | Lee, H.J. | - |
dc.date.accessioned | 2021-06-18T13:44:15Z | - |
dc.date.available | 2021-06-18T13:44:15Z | - |
dc.date.issued | 2003-08-30 | - |
dc.identifier.issn | 0513-5796 | - |
dc.identifier.issn | 1976-2437 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/47180 | - |
dc.description.abstract | Antimicrobial resistance surveillance is necessary to determine the size of the problem and to guide empirical selection of antimicrobial agents for treating infected patients. The aim of this study was to analyze the results of susceptibility tests performed by hospitals participating in the Korean Nationwide Surveillance of Antimicrobial Resistance (KONSAR) program. The rates of oxacillin-resistant staphylococci, penicillin-non-susceptible pneumococci, and ampicillin-resistant E. faecium were over 70%. Ampicillin-resistant H. influenzae increased to 68%. Expanded-spectrum cephalosporin-resistant K. pneumoniae, fluoroquinolone-resistant E. coli, and imipenem-resistant P. aeruginosa remained at 16% through 27%, depending on the species. The proportions of vancomycin- resistant E. faecium and imipenem-resistant P. aeruginosa were 18 - 24% and 19-21%, respectively, indicating the seriousness of antimicrobial resistance. In conclusion, the increasing prevalence of resistant bacteria indicates that more concerted effort is required to conserve the usefulness of precious new antimicrobial agents. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Yonsei University College of Medicine | - |
dc.title | Korean Nationwide Surveillance of Antimicrobial Resistance in 2000 with special reference to vancomycin resistance in enterococci, and expanded-spectrum cephalosporin and imipenem resistance in gram-negative bacilli | - |
dc.type | Article | - |
dc.identifier.doi | 10.3349/ymj.2003.44.4.571 | - |
dc.identifier.bibliographicCitation | Yonsei Medical Journal, v.44, no.4, pp 571 - 578 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-0042381260 | - |
dc.citation.endPage | 578 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 571 | - |
dc.citation.title | Yonsei Medical Journal | - |
dc.citation.volume | 44 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Antimicrobial resistance | - |
dc.subject.keywordAuthor | Korean resistance surveillance | - |
dc.subject.keywordAuthor | Pathogenic bacteria | - |
dc.subject.keywordPlus | amikacin | - |
dc.subject.keywordPlus | ampicillin | - |
dc.subject.keywordPlus | antibiotic agent | - |
dc.subject.keywordPlus | cefalotin | - |
dc.subject.keywordPlus | cefepime | - |
dc.subject.keywordPlus | cefotaxime | - |
dc.subject.keywordPlus | cefoxitin | - |
dc.subject.keywordPlus | ceftazidime | - |
dc.subject.keywordPlus | cephalosporin | - |
dc.subject.keywordPlus | cotrimoxazole | - |
dc.subject.keywordPlus | erythromycin | - |
dc.subject.keywordPlus | gentamicin | - |
dc.subject.keywordPlus | imipenem | - |
dc.subject.keywordPlus | meticillin | - |
dc.subject.keywordPlus | oxacillin | - |
dc.subject.keywordPlus | penicillin G | - |
dc.subject.keywordPlus | piperacillin | - |
dc.subject.keywordPlus | piperacillin plus tazobactam | - |
dc.subject.keywordPlus | quinoline derived antiinfective agent | - |
dc.subject.keywordPlus | sultamicillin | - |
dc.subject.keywordPlus | tetracycline | - |
dc.subject.keywordPlus | vancomycin | - |
dc.subject.keywordPlus | Acinetobacter | - |
dc.subject.keywordPlus | antibiotic resistance | - |
dc.subject.keywordPlus | antibiotic sensitivity | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | drug use | - |
dc.subject.keywordPlus | Enterobacter cloacae | - |
dc.subject.keywordPlus | Enterococcus | - |
dc.subject.keywordPlus | Enterococcus faecium | - |
dc.subject.keywordPlus | Escherichia coli | - |
dc.subject.keywordPlus | Gram negative bacterium | - |
dc.subject.keywordPlus | Haemophilus influenzae | - |
dc.subject.keywordPlus | health program | - |
dc.subject.keywordPlus | health survey | - |
dc.subject.keywordPlus | Klebsiella pneumoniae | - |
dc.subject.keywordPlus | Korea | - |
dc.subject.keywordPlus | medical decision making | - |
dc.subject.keywordPlus | methicillin resistant Staphylococcus aureus | - |
dc.subject.keywordPlus | patient care | - |
dc.subject.keywordPlus | prevalence | - |
dc.subject.keywordPlus | Pseudomonas aeruginosa | - |
dc.subject.keywordPlus | Serratia marcescens | - |
dc.subject.keywordPlus | species difference | - |
dc.subject.keywordPlus | Staphylococcus | - |
dc.subject.keywordPlus | Streptococcus pneumoniae | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.